Search

everythinglearnresearchcommunity

for

Search:↓

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Skin issues can indicate immune system problems.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

Skin problems can indicate different diseases inside the body.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

JAK inhibitors help with skin conditions but need more research on dosing and safety.